Recombinant Pig Mitochondrial Uncoupling Protein 2 (UCP2) is a genetically engineered version of the endogenous protein expressed in pigs (Sus scrofa). UCP2 belongs to the mitochondrial anion carrier family and plays a critical role in regulating proton leak across the inner mitochondrial membrane, thereby modulating energy metabolism, reactive oxygen species (ROS) production, and cellular survival . Recombinant UCP2 is widely used in research to study its structural, functional, and therapeutic roles in metabolic and degenerative diseases.
Primary Structure: Recombinant Pig UCP2 consists of 309 amino acids with a molecular weight of ~33 kDa .
Gene Structure: The UCP2 gene in pigs spans 4.2–4.5 kb with 8 exons and 7 introns, conserved across vertebrates .
Expression System: Produced in E. coli via in vitro expression, ensuring high yield and purity .
Storage: Stable at -20°C or -80°C; repeated freeze-thaw cycles are discouraged .
Proton Uncoupling: UCP2 facilitates proton leakage, reducing mitochondrial membrane potential (Δψ) and ROS production while dissipating energy as heat .
ATP Modulation: By altering proton flux, UCP2 indirectly regulates ATP/ADP ratios, impacting insulin secretion and cellular energy balance .
ROS Scavenging: UCP2 mitigates oxidative stress by lowering mitochondrial ROS, protecting against ischemia-reperfusion injury and neurodegeneration .
Cell Survival: Overexpression of UCP2 prevents mitochondrial permeability transition pore (mPTP) activation, reducing apoptosis in cardiomyocytes and neurons .
Lipid Metabolism: UCP2 influences fatty acid oxidation and lipid storage, with implications for obesity and diabetes .
Immune Regulation: UCP2 suppresses mast cell activation by reducing histamine release and ERK phosphorylation .
Neurodegenerative Studies: UCP2 overexpression protects against MPP⁺-induced toxicity in Parkinson’s disease models by maintaining ATP and mitochondrial membrane potential .
Cardiovascular Research: UCP2 attenuates H₂O₂-induced mitochondrial Ca²⁺ overload and ROS in cardiomyocytes, offering cardioprotective insights .
Cancer Metabolism: UCP2 silencing alters glucose and glutamine oxidation, highlighting its role in tumor bioenergetics .
Diabetes: UCP2 modulates β-cell ROS, affecting insulin secretion and glucose homeostasis .
Hypertension: UCP2 downregulation exacerbates renal and cerebrovascular damage in hypertensive models .
Aging and Cancer: UCP2 induces G₁-phase cell cycle arrest and non-apoptotic death in hepatocytes, suggesting roles in aging and cancer .
Functional Controversies: While UCP2 is implicated in metabolic uncoupling, recent studies emphasize its role as a metabolite transporter (e.g., exporting C4 compounds like malate) .
Therapeutic Targeting: Developing UCP2 agonists/antagonists requires resolving tissue-specific effects and downstream signaling pathways .
UCP2 is an inner mitochondrial membrane protein belonging to the uncoupling protein family. Its primary function involves lowering mitochondrial membrane potential and dissipating metabolic energy, thereby preventing oxidative stress accumulation . Unlike UCP1 (primarily expressed in brown adipose tissue for thermogenesis), UCP2 displays broader tissue distribution and plays crucial roles in ROS regulation across multiple systems.
The mild uncoupling theory explaining UCP2's ROS-regulating function was first identified through experiments demonstrating that UCP2 inhibition causes a rapid increase of H₂O₂ . In Ucp2-/- mice, increased mitochondrial ROS production is observed, which enhances phagocytosis of infectious agents in macrophages .
UCP2 displays approximately 60% sequence identity with UCP1 . The genes encoding UCP2 and UCP3 are adjacent in all species, mapping to mouse chromosome 7, rat chromosome 1, and human chromosome 11 .
Methodological approach:
When designing experiments with recombinant pig UCP2, researchers should consider:
In vitro systems:
Reconstituted proteoliposome systems with purified recombinant pig UCP2
Isolated mitochondria with incorporated recombinant protein
Cell culture models transfected with pig UCP2 expression vectors
Knockout/knockdown models:
CRISPR-Cas9 mediated UCP2 gene editing in porcine cell lines
siRNA approaches in pig-derived cells
Comparative models:
Parallel experiments with human and pig UCP2 to identify species-specific differences
Chimeric proteins to identify functional domains
Experimental readouts should include membrane potential measurements, ROS production assays, oxygen consumption rates, and proton leak assessments to comprehensively characterize UCP2 function .
Methodological guidance:
While the search results don't specifically address pig UCP2 expression systems, researchers should consider these approaches based on membrane protein expression principles:
Expression systems selection:
E. coli systems: Suitable for high yield but may require refolding
Yeast expression: P. pastoris often provides better folding for membrane proteins
Insect cell/baculovirus: Preferred for maintaining native structure of mammalian membrane proteins
Mammalian expression: HEK293 or CHO cells for authentic post-translational modifications
Purification strategies:
Extraction using mild detergents (DDM, LMNG) to maintain protein integrity
Affinity chromatography with carefully positioned tags that don't interfere with function
Size exclusion chromatography to ensure homogeneity
Lipid reconstitution to restore native-like environment
Functional verification:
Proton transport assays in proteoliposomes
Patch-clamp electrophysiology
Thermal stability assays
Binding assays for known regulators
The cloning approach described for creating genetically modified pigs could potentially be adapted for UCP2 expression: "Once you have a live pig that contains the desired genes, cloning can make many copies of that pig... Wait three months, three weeks, and three days—the gestation period of a sow—and, hopefully, you get a litter of identical pigs expressing the genes you want" .
UCP2 functions as a critical regulator of mitochondrial ROS production through its mild uncoupling activity. The mechanism involves:
Slight dissipation of the proton gradient across the inner mitochondrial membrane
Reduction of mitochondrial membrane potential
Decreased electron leakage from the respiratory chain
Methodological approaches to measure UCP2-mediated ROS regulation:
| Technique | Application | Advantages | Limitations |
|---|---|---|---|
| High-resolution respirometry | Measures oxygen consumption and OXPHOS efficiency | Quantitative, detects subtle changes | Requires specialized equipment |
| Fluorescent ROS indicators | Direct measurement of H₂O₂, superoxide | Real-time monitoring possible | Potential artifacts, probe specificity |
| Membrane potential dyes (TMRM, JC-1) | Quantifies Δψm changes | Direct measurement of UCP2 primary effect | Some dyes affect mitochondrial function |
| Lipid peroxidation assays | Measures downstream effects of ROS | Indicates physiological impact | Indirect measurement of UCP2 activity |
| EPR spectroscopy | Direct detection of free radicals | Highly specific | Technical complexity |
Knockout studies have demonstrated that Ucp2-/- mice exhibit increased mitochondrial ROS production, confirming UCP2's critical role in regulating oxidative stress .
UCP2 demonstrates complex roles in cancer biology, functioning as both a potential tumor promoter and suppressor depending on cancer type and context:
Cancer resistance mechanisms involving UCP2:
Research has demonstrated that "mitochondrial uncoupling by UCP2 is a mechanism of cancer cell resistance to the standard chemotherapeutic drug gemcitabine by regulating mitochondrial superoxide production" . UCP2 inhibition has shown a synergistic antiproliferative effect with gemcitabine in pancreatic adenocarcinoma cells .
UCP2 in cancer prognosis:
Pan-cancer analysis revealed varied prognostic significance of UCP2 expression:
| Cancer Type | HR Value | p-value | Association |
|---|---|---|---|
| KIRP | 1.336 | 0.018 | Risk factor |
| LAML | 1.921 | 0.0002 | Risk factor |
| LGG | 1.392 | 0.0002 | Risk factor |
| CESC | 0.719 | 0.004 | Improved survival |
| LUAD | 0.766 | 0.008 | Improved survival |
| OV | 0.849 | 0.019 | Improved survival |
| SARC | 0.782 | 0.011 | Improved survival |
Methodological approaches for investigating UCP2 in cancer:
Xenograft models with UCP2-modulated cancer cells
Patient-derived organoids with UCP2 inhibition/overexpression
Co-treatment strategies combining UCP2 modulators with standard chemotherapeutics
Metabolic flux analysis to determine how UCP2 affects cancer cell bioenergetics
Single-cell RNA sequencing to identify UCP2-expressing populations within tumors
UCP2 has significant effects on immune function and the tumor microenvironment, particularly in cancer contexts:
Immune pathway correlations:
KEGG enrichment analysis revealed that high UCP2 expression correlates with upregulated immune-related pathways, including:
GO enrichment results similarly showed UCP2 expression associations with:
Antigen receptor-mediated signaling
T cell differentiation in immune responses
Antigen processing and presentation
Immune cell correlations:
UCP2 correlates positively with CD8+ T cells and M1 macrophages, while negatively with M2 macrophages in breast cancer, suggesting "UCP2 may suppress tumor proliferation by regulating CD8+ T cell infiltration and macrophage polarization" .
Methodological approaches:
Flow cytometry to quantify immune cell populations in UCP2-modulated models
Multiplex cytokine assays to assess inflammatory mediator profiles
Immune cell co-culture systems with UCP2-modified cancer cells
In vivo models evaluating immunotherapy response in UCP2-modulated tumors
Spatial transcriptomics to map UCP2 expression relative to immune infiltrates
UCP2 plays a critical protective role in cardiovascular health:
Vascular protection: UCP2 "is being increasingly recognized as an important molecule to defend against various stress signals such as oxidative stress" in the cardiovascular system .
Atherosclerosis: "The deletion of the UCP2 gene contributes to atherosclerosis lesion development in the knockout mice, also showing significantly shorter lifespan" .
Hypertension: "UCP2 gene downregulation is a key determinant of higher predisposition to renal and cerebrovascular damage in an animal model of spontaneous hypertension and stroke" .
Endothelial function: "UCP2 overexpression improves both hyperglycemia- and high-salt diet-induced endothelial dysfunction and ameliorates hypertensive target organ damage" .
Methodological approaches using recombinant pig UCP2:
Ex vivo perfusion studies of pig coronary vessels with recombinant UCP2
Incorporation of recombinant UCP2 into cardiomyocyte cultures under stress conditions
Comparative studies between native and recombinant UCP2 in pig cardiovascular tissues
Development of UCP2-targeted nanoparticles for localized delivery to vascular lesions
Non-invasive imaging to track ROS in cardiovascular tissues following UCP2 modulation
UCP2 is regulated at multiple levels, requiring comprehensive methodological approaches:
| Regulatory Level | Techniques | Applications |
|---|---|---|
| Transcriptional | ChIP-seq, ATAC-seq | Identify transcription factor binding sites and chromatin accessibility |
| Post-transcriptional | RNA-seq, ribosome profiling | Analyze mRNA stability and translation efficiency |
| Post-translational | Mass spectrometry, phosphoproteomics | Identify modifications affecting UCP2 function |
| Protein-protein interactions | BioID, proximity labeling | Map UCP2 interactome in native environment |
| Protein dynamics | FRAP, single-molecule tracking | Analyze UCP2 mobility and turnover in mitochondria |
| Structural dynamics | Cryo-EM, HDX-MS | Determine UCP2 conformational changes |
Methodological considerations:
When designing experiments to investigate UCP2 regulation, researchers should:
Use multiple complementary approaches to confirm findings
Consider tissue-specific and context-dependent regulation
Develop time-course experiments to capture dynamic regulation
Apply systems biology approaches to integrate multi-omics data
Validate findings across species to identify conserved regulatory mechanisms
Methodological approach:
Mitochondrial morphology analysis:
Super-resolution microscopy (STED, STORM) to visualize UCP2 distribution
Live-cell imaging with mitochondrial markers to track fusion/fission events
Electron microscopy to assess cristae structure in UCP2-modulated mitochondria
Mitophagy assessment:
mt-Keima pH-sensitive reporters to quantify mitophagy flux
Colocalization of mitochondrial markers with autophagy proteins
Western blot analysis of PINK1/Parkin pathway components
Mitochondrial quality control:
Measurement of mitochondrial DNA damage and mutation rates
Protein oxidation and carbonylation assays
Mitochondrial proteomics to assess protein turnover
Advanced functional assays:
Seahorse XF analysis with specific inhibitors to isolate UCP2 contributions
Patch-clamp of mitoplasts to directly measure proton conductance
In situ calcium imaging to assess mitochondrial calcium handling
Genetic approaches:
CRISPR-interference for temporal control of UCP2 expression
Optogenetic control of UCP2 activity
Mitochondria-targeted transcription factors to modulate UCP2 expression
The research showing that "UCP2 inhibition triggers ROS-dependent nuclear translocation of the glycolytic enzyme GAPDH and autophagic cell death" highlights the importance of studying UCP2 in the context of broader cellular quality control mechanisms .